In November of 2021, the Food and Drug Administration (FDA) approved Cytalux. Cytalux is a new imaging drug intended to assist surgeons with the identification of ovarian cancer lesions1. This new drug was designed to assist in locating additional ovarian cancer tissues that can be…
The Food and Drug Administration (FDA) recently debuted a new eligible health claim for magnesium. In early January...
For a long time, healthcare was in the hands of doctors. People listened only to their doctor’s advice on how...
Ovarian cancer is one of the most common forms of cancer affecting female-born patients. About 21,000 people...
Movies, books, and television shows have imagined what the world will look like in the future. From flying cars to...
As new technologies continuously push the limits of medical devices and drugs, regulations and governing...
Becton, Dickinson, and Company, or BD, announced on August 27, that the US Food and Drug Administration (FDA)...
This past Monday, the FDA announced fiscal year (FY) 2022 medical device user fees. This upcoming fiscal year...
The day has come where the U.S. Food and Drug Administration finally approves the first COVID-19 vaccination for...
X-ray diffraction (XRD) is a non-destructive laboratory technique that assesses the lattice spacing of...
Temperature mapping has become increasingly integrated into regular operations for those who produce or handle...
Women and men are different in many aspects when it comes to disease-causing pathogens. An interesting fact is that...
